Omega Fund Management, LLC Nuvation Bio Inc. Transaction History
Omega Fund Management, LLC
- $96.6 Million
- Q1 2024
A detailed history of Omega Fund Management, LLC transactions in Nuvation Bio Inc. stock. As of the latest transaction made, Omega Fund Management, LLC holds 14,072,340 shares of NUVB stock, worth $42.8 Million. This represents 53.03% of its overall portfolio holdings.
Number of Shares
14,072,340
Previous 15,072,340
6.63%
Holding current value
$42.8 Million
Previous $22.8 Million
125.07%
% of portfolio
53.03%
Previous 27.87%
Shares
7 transactions
Others Institutions Holding NUVB
# of Institutions
126Shares Held
107MCall Options Held
40.6KPut Options Held
2.9K-
Eco R1 Capital, LLC San Francisco, CA19.2MShares$58.4 Million1.99% of portfolio
-
Black Rock Inc. New York, NY12.5MShares$38.1 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.53MShares$22.9 Million0.0% of portfolio
-
David Abrams Abrams Capital Management, L.P. | Boston, Ma3.81MShares$11.6 Million0.47% of portfolio
-
Tang Capital Management LLC San Diego, CA3.55MShares$10.8 Million1.57% of portfolio
About Nuvation Bio Inc.
- Ticker NUVB
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 217,244,000
- Market Cap $660M
- Description
- Nuvation Bio Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutic candidates for oncology. The company's lead product candidate is NUV-422, a small molecule inhibitor targeting cyclin-dependent kinase (CDK)2, CDK4, and CDK6. It is also developing NUV-868, a selective oral small molecule BET inhibitor that e...